Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This multimodal local anesthetic cocktail was developed by the Lahey Clinic for perioperative pain management in patients undergoing operative fixation of ankle fractures. The formulation consists of ropivacaine (a long-acting amide local anesthetic), clonidine (an alpha-2 adrenergic agonist used as an analgesic adjuvant), and epinephrine (a vasoconstrictor used to prolong the duration of the block). It is administered via local infiltration at the surgical site. The cocktail is being evaluated in a Phase 4 clinical trial (NCT03696199) to compare its efficacy against regional anesthesia (nerve blocks) and traditional care. The combination aims to provide extended regional pain control by blocking nerve conduction while minimizing systemic absorption and enhancing the analgesic effect through synergistic pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ropivacaine + clonidine + epinephrine.